Pharming Group N.V.
Joenja
APDS
Resolved
103days ago
Advisory committee · Mar 26, 2026
What's at stake
An FDA advisory committee reviews Joenja for APDS around Mar 26, 2026. The panel's public vote often front-runs the agency's final verdict — and the share price.
Primary source
· SEC 6-K
verified 12h ago
“we held a Type A meeting with the FDA on March 26, 2026, to discuss the issues outlined in the letter and align on a path forward for resubmission.”